- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
APP changes name to Radiologix
American Physician Partners has changed its name, effective Sept. 24, to Radiologix. The Dallas company’s stock symbol changed from APPM to RDLX three days later, and continues to trade on the Nasdaq exchange. The move comes just weeks after the
American Physician Partners has changed its name, effective Sept. 24, to Radiologix. The Dallas companys stock symbol changed from APPM to RDLX three days later, and continues to trade on the Nasdaq exchange. The move comes just weeks after the company acquired imaging center operator Questar Imaging in a deal valued at $44.6 million (SCAN 8/18/99). The Questar deal made Radiologix one of the largest operators of radiology centers in the U.S.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
